14 completed, 4 unknown, 3 recruiting, 1 terminated. 22 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 22 | Completed 14, Unknown 4, Recruiting 3, Terminated 1 |
Follow Autistic Disorder: new trials by email Literature Review of Autistic Disorder trials Research Report on Autistic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Buspirone for Anxiety in Autistic Youth buspirone, Placebo - Anxiety, Autism Spectrum Disorder | Phase 4 | Recruiting | Massachusetts General Hospital | 20 | 2026-09-01 | 2026-09-17 |
| The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine Adderall XR (mixed salts amphetamine), Placebo - Attention Deficit Hyperactivity Disorder (ADHD), Autism | Phase 4 | Recruiting | Gagan Joshi | 196 | 2026-02-01 | 2026-03-06 |
| AWARE: Management of ADHD in Autism Spectrum Disorder Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant. - ADHD, Autism Spectrum Disorder | Phase 4 | Recruiting | Daniel Coury | 500 | 2023-10-01 | 2026-10-22 |
| Intranasal Dexmedetomidine vs Oral Triclofos Sodium for EEG in Children With Autism Dexmedetomidine, Triclofos 100 MG/ML - Autistic Disorder | Phase 4 | Unknown | Rabin Medical Center | 200 | 2020-03-01 | 2020-02-17 |
| A Study of Glutathione in Children With Autism Spectrum Disorder Glutathione - Autism Spectrum Disorder | Phase 4 | Terminated | University of Chicago | 6 | 2019-07-01 | 2025-09-18 |
| Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD) Open-label Treatment with Omega-3 Fatty Acids + Inositol, Open-label Treatment with N-acetylcysteine - Non-verbal Learning Disorder, Autism Spectrum Disorder | Phase 4 | Completed | Massachusetts General Hospital | 54 | 2019-05-20 | 2025-06-05 |
| Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes Enhanced early detection - Autism Spectrum Disorder | Phase 4 | Completed | Drexel University | 2087 | 2017-11-29 | 2024-08-16 |
| Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Very Low Dose Quillivant XR, Low Dose Quillivant XR, Moderate Dose Quillivant XR - ADHD, Autism | Phase 4 | Completed | Seattle Children's Hospital | 36 | 2014-09-01 | 2017-08-01 |
| Study to Evaluate the Efficacy and Safety of Aripiprazole Aripiprazole - Autism | Phase 4 | Unknown | Yoo-Sook Joung | 79 | 2014-02-01 | 2014-03-11 |
| Multisite Study: Parental Training Using Video Modelling to Develop Social Skills in Children With Autism ABA parent training - Autism Spectrum Disorders | Phase 4 | Completed | Federal University of São Paulo | 67 | 2014-02-01 | 2015-04-02 |
| An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum Gammaplex 5% - Autism, Autistic Disorder | Phase 4 | Unknown | Isaac Melamed | 30 | 2013-06-01 | 2015-04-16 |
| Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder placebo, extended-release guanfacine - Pervasive Development Disorders | Phase 4 | Completed | Yale University | 62 | 2011-12-01 | 2020-03-31 |
| Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) Aripiprazole, Risperidone - Autistic Disorder | Phase 4 | Completed | Medical University of South Carolina | 80 | 2011-07-01 | 2018-09-26 |
| Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism Milnacipran, Placebo - Autism Spectrum Disorder, Asperger Syndrome | Phase 4 | Completed | Montefiore Medical Center | 10 | 2011-02-01 | 2020-02-27 |
| Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders Acetyl-Choline Esterase Inhibitors and Choline supplements, Indistinguishable placebo tablets, matching both donepezil and choline - Autism | Phase 4 | Unknown | Sheba Medical Center | 84 | 2010-03-01 | 2016-10-14 |
| A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children Risperidone, Other atypical antipsychotic drugs - Schizophrenia, Bipolar Disorder | Phase 4 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 244 | 2009-10-01 | 2012-11-27 |
| FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders Aripiprazole - Autism Spectrum Disorder | Phase 4 | Completed | University of North Carolina, Chapel Hill | 13 | 2009-08-01 | 2014-03-11 |
| Atomoxetine, Placebo and Parent Management Training in Autism atomoxetine, Placebo, Parent Management Training - Autism, Pervasive Development Disorder | Phase 4 | Completed | University of Rochester | 128 | 2008-10-01 | 2016-02-04 |
| A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder Placebo, Risperidone high dose, Risperidone low dose - Autistic Disorder, Autism | Phase 4 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 96 | 2007-12-01 | 2014-05-09 |
| Minocycline to Treat Childhood Regressive Autism Minocycline - Autism, Minocycline | Phase 4 | Completed | National Institute of Mental Health (NIMH) | 11 | 2006-11-01 | 2015-12-11 |
Showing 20 of 22. Sign in to see all of them.
Autism Spectrum Disorder (9) · Attention Deficit Disorder with Hyperactivity (6) · Asperger Syndrome (4) · Child Development Disorders, Pervasive (3) · Aggression (1) · Anxiety Disorders (1) · Behavior (1) · Bipolar Disorder (1) · Compulsive Behavior (1) · Learning Disabilities (1) · Schizophrenia (1) · Spasm (1) · cyclopia sequence (1)
Mental Disorders (22) · Neurodevelopmental Disorders (22) · Child Development Disorders, Pervasive (19) · Autism Spectrum Disorder (13) · Attention Deficit and Disruptive Behavior Disorders (6) · Behavior (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Aberrant Motor Behavior in Dementia (1) · Behavioral Symptoms (1) · Bipolar and Related Disorders (1) · Communication Disorders (1) · Impulsive Behavior (1)
Aripiprazole (3) · Risperidone (3) · Atomoxetine Hydrochloride (2) · Methylphenidate (2) · 5,10-dihydro-5-methylphenazine (1) · Acetylcysteine (1) · Adenosine Monophosphate (1) · Buspirone (1) · Choline (1) · Dexmedetomidine (1) · Fatty Acids, Omega-3 (1) · Glutathione (1) · Guanfacine (1) · Inositol (1) · Milnacipran (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Massachusetts General Hospital (2) · Montefiore Medical Center (2) · Daniel Coury (1) · Drexel University (1) · Eli Lilly and Company (1) · Federal University of São Paulo (1) · Gagan Joshi (1) · Isaac Melamed (1) · Medical University of South Carolina (1) · National Institute of Mental Health (NIMH) (1) · Rabin Medical Center (1) · Seattle Children's Hospital (1) · Sheba Medical Center (1) · University of Chicago (1)
United States (17) · Netherlands (2) · Belgium (1) · Brazil (1) · Canada (1) · Germany (1) · Greece (1) · Israel (1) · Philippines (1) · Poland (1) · South Korea (1) · Thailand (1)
Eric Hollander, MD (2) · Benjamin Handen, PhD (1) · Bryan King, MD (1) · C. Lindsay DeVane, Pharm.D. (1) · Cheryl O Alderman, BS (1) · Christopher McDougle, MD (1) · Daniel Coury, MD (1) · Diana Robins, PhD (1) · Dorit Ben-Shalom, Ph.D (1) · Gabriel Dichter, PhD (1) · Gagan Joshi, MD (1) · Isaac Melamed, MD (1) · James Dziura, MPH, PhD (1)
PMID 37811711, PMID 12472704, PMID 20377705, PMID 21318594, PMID 22704249, PMID 22721596, PMID 23212807, PMID 23566357, PMID 23578015, PMID 24018545, PMID 24350813, PMID 24532346, PMID 24823763, PMID 25019647, PMID 25246305, PMID 25369243, PMID 26231264, PMID 26506581, PMID 26814037, PMID 26936022, PMID 27663942, PMID 28347608, PMID 28455770, PMID 29022125, PMID 29694241, PMID 29701730, PMID 30982953, PMID 31063671, PMID 31292919, PMID 31447530, PMID 31862730, PMID 33934719, PMID 36112116, PMID 36808953, PMID 3706808, PMID 37267443, PMID 39454668, PMID 8632499, PMID 9060867
K23MH081285 (1), R01MH083707 (1)